1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
67ACD1F7170D44F02652584340045F0D3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-factors-drive-results-biopharmaceutical-sales-training-programs-operations-models-content-delivery-development?opendocument
18
19opendocument
2018.205.96.39
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales Leadership Sales Training

Factors That Drive Results for Biopharmaceutical Sales Training Programs: Operations, Models, Content Delivery and Development

ID: 5565


Features:

19 Info Graphics

14 Data Graphics

150+ Metrics

16 Narratives


Pages/Slides: 41


Published: 2019


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Factors That Drive Results for Biopharmaceutical Sales Training Programs: Operations, Models, Content Delivery and Development”

STUDY OVERVIEW

In the rapidly changing biopharmaceutical industry, sales training plays an integral role in not only bringing new hires up to speed but also keeping the rest of the sales force up to date. To ensure sales training effectiveness, it is important to strengthen curriculum development and delivery as well as collaboration with internal stakeholders.

Best Practices, LLC undertook this benchmarking research to identify the operational models and content delivery approaches that drive effectiveness in high-performing sales training departments across the biopharmaceutical industry. This study delivers benchmarks around sales training program attributes, curriculum, content development and delivery, training venues, time allocation, and collaboration levels.

KEY TOPICS

  • Sales training program attributes
  • Collaboration level of sales training with various stakeholder groups
  • Performance measurement
  • Sales training curriculum
  • Sales training content development and delivery
  • Training venues
  • Time allocation for sales training at annual and regional meetings

KEY METRICS

  • Rate the level of collaboration that Sales Training function has with each stakeholder group
  • Which of the listed statements describe your Sales Training function's performance measurement process?
  • Rate each of the listed metrics for evaluating the quality of the Sales Training function
  • Approximately what percentage of your sales rep trainees achieve their first-year sales goals?
  • Which of the listed kinds of sales training are included in your organization's formal curriculum?
  • What percentage of your formal (scheduled) sales training content is developed and delivered by each of the listed groups?
  • Approximately what percentage of your sales training is delivered using each of the listed approaches? What percentage of your total sales training (including new hires) is provided in each of the listed venues?
  • Approximately what percentage of total time is typically allotted for sales training at annual and regional meetings (such as POA)?

SAMPLE KEY FINDINGS

  • Training performance is evaluated by individual’s competency: Over 80% of participants measure individual competencies to assess sales training performance. Team competency is measured in 40% of the training groups while regional competency has less significance.

METHODOLOGY

Best Practices, LLC engaged 56 sales training leaders from 36 pharmaceutical and biotech companies through a benchmarking survey. Research analysts also conducted six deep-dive executive interviews with selected benchmark participants. More than half of the benchmark participants serve at the director level and above.

Industries Profiled:
Biotech; Pharmaceutical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Chemical; Health Care; Biopharmaceutical; Clinical Research; Laboratories; Professional Services


Companies Profiled:
Allergan; Arbor; Astellas; AstraZeneca; Avion Pharmaceuticals; LLC; Baxter Healthcare; Bayer; Biogen; Celgene; Dr Reddy's Laboratories; Eisai; Eli Lilly; EMD Serono; EryDel; Genentech; Grifols; Ipsen; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Lundbeck; Merck; Novartis; OTSUKA; Pernix Therapeutics; Pfizer; Sanofi; Shire; Strategic Outcomes; Sunovion; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd; UCB Pharma; Valeant; Verastem Oncology; Zydus Cadila

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.